Ribocure Clinic marks milestone with first patient enrolled in a deep phenotyping clinical study

With the ambition to become the leading clinical oligonucleotide research company in Sweden, Ribocure Pharmaceuticals AB established Ribocure Clinic, with a vision to drive excellence in proof of principle/concept clinical trials with an in-house high volume and high quality Ph2 clinical trial unit.

Now the first patient has been enrolled in a deep phenotyping study paving the way to identify “right patients” to “right interventional trial”, a precision medicine approach that represents one of the important cornerstones in our effort driving clinical excellence.   

Ribocure Clinic is a Ph2 clinical trial unit situated at the company’s premises at GoCo Clinic in Gothenburg, Sweden. Here, patients are welcomed to clinical trial participation by experienced and highly trained medical research staff specialized in clinical trial execution, in particular complex Ph2 trial endpoints in cardiovascular, pulmonary, renal and liver areas where advanced imaging and functional assessments are required. It is a remarkable achievement that it took less than two working months from our move to GoCo Clinic, until we established all SOPs as well as received all necessary certificates and permissions from various authorities, and finally the official First-Patient-In status. This milestone reflects the professionalism, dedication and efficiency of our high-performing clinical team.

Ribocure Pharmaceuticals would also like to highlight the dedicated teams at data management and quality assurance who have put relentless effort into making this milestone a reality.

Share on social media

Recommended articles

Privacy Policy (Integritetspolicy)
Your privacy is important to us. Ribocure Pharmaceuticals AB respects your privacy regarding all data we may collect from you on our website, www.ribocure.com.
 
We collect data/information to make contact and establish and maintain a relationship. We collect this information in a fair and legal way with your awareness and consent, as stipulated by GDPR (General Data Protection Regulation). We also let you know why we collect it and how it will be used.
 
The data that is stored are the fields that each submission form contains. We save the data for as long as is necessary with regard to the purposes of the processing. We always base the collection of personal data on consent.
 
You have the right to request information about what personal data we have stored about you. To do this, contact the Data Protection Officer (DPO). You also have the right to request correction or deletion of your personal data at any time.
 
Your continued use of our website will be deemed as acceptance of our privacy and personal information practices. If you have any questions about how we handle user data and personal information, please contact us.
 
Contact information to the Data Protection Officer (DPO):
 
Data Protection Officer
Ribocure Pharmaceuticals AB
Vetenskapens gränd 11
431 53 Mölndal
Sweden
 
E-mail: dpo@ribocure.com